Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Public ClinicalTrials.gov record NCT01858519. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Point Prevalence Study to Evaluate the Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Who Are Receiving Porcine-Derived Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a point prevalence study conducted entirely in the United States (US) to establish the prevalence of antibodies to hepatitis E virus (HEV) and other selected porcine viruses in cystic fibrosis (CF) patients receiving pancreatic enzyme replacement therapy (PERT) for pancreatic insufficiency compared with matched (age and region of residence) control patients with chronic medical conditions unexposed to PERT.
Study identification
- NCT ID
- NCT01858519
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,310 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 2 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2013 (Type not available)
- Primary completion
- Sep 2016 (Actual)
- Completion
- Sep 2016 (Actual)
- Last update posted
- Dec 9, 2020
2013 – 2016
United States locations
- U.S. sites
- 47
- U.S. states
- 28
- U.S. cities
- 44
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 116382 | Anchorage | Alaska | 99508 | — |
| Site Reference ID/Investigator# 116444 | Little Rock | Arkansas | 72202 | — |
| Site Reference ID/Investigator# 116595 | Long Beach | California | 90806 | — |
| Site Reference ID/Investigator# 116855 | Los Angeles | California | 90027 | — |
| Site Reference ID/Investigator# 116879 | Los Angeles | California | 90027 | — |
| Site Reference ID/Investigator# 116448 | Los Angeles | California | 90033 | — |
| Site Reference ID/Investigator# 154681 | Denver | Colorado | 80206-2761 | — |
| Site Reference ID/Investigator# 116441 | Hartford | Connecticut | 06106 | — |
| Site Reference ID/Investigator# 127584 | New Haven | Connecticut | 06510 | — |
| Site Reference ID/Investigator# 116440 | Gainesville | Florida | 32610 | — |
| Site Reference ID/Investigator# 116882 | Miami | Florida | 33136 | — |
| Site Reference ID/Investigator# 116277 | Orlando | Florida | 32803 | — |
| Site Reference ID/Investigator# 116435 | Tampa | Florida | 33606 | — |
| Site Reference ID/Investigator# 131935 | Atlanta | Georgia | 30125 | — |
| Site Reference ID/Investigator# 116452 | Boise | Idaho | 83712 | — |
| Site Reference ID/Investigator# 116442 | Chicago | Illinois | 60611-2291 | — |
| Site Reference ID/Investigator# 116465 | Maywood | Illinois | 60153 | — |
| Site Reference ID/Investigator# 141881 | Niles | Illinois | 60714 | — |
| Site Reference ID/Investigator# 127295 | Peoria | Illinois | 61603 | — |
| Site Reference ID/Investigator# 116877 | Indianapolis | Indiana | 46202 | — |
| Site Reference ID/Investigator# 116436 | Wichita | Kansas | 67214 | — |
| Site Reference ID/Investigator# 136816 | Louisville | Kentucky | 40202 | — |
| Site Reference ID/Investigator# 116450 | New Orleans | Louisiana | 70112 | — |
| Site Reference ID/Investigator# 116455 | Shreveport | Louisiana | 71103 | — |
| Site Reference ID/Investigator# 116461 | Boston | Massachusetts | 02115 | — |
| Site Reference ID/Investigator# 116463 | Grand Rapids | Michigan | 49503 | — |
| Site Reference ID/Investigator# 116445 | Jackson | Mississippi | 39216 | — |
| Site Reference ID/Investigator# 116883 | Omaha | Nebraska | 68198 | — |
| Site Reference ID/Investigator# 116876 | Buffalo | New York | 14222 | — |
| Site Reference ID/Investigator# 130461 | New Hyde Park | New York | 11040 | — |
| Site Reference ID/Investigator# 116449 | Syracuse | New York | 13210 | — |
| Site Reference ID/Investigator# 116458 | Cincinnati | Ohio | 45267-0564 | — |
| Site Reference ID/Investigator# 116276 | Toledo | Ohio | 43606 | — |
| Site Reference ID/Investigator# 116464 | Oklahoma City | Oklahoma | 73104 | — |
| Site Reference ID/Investigator# 116457 | Hershey | Pennsylvania | 17033 | — |
| Site Reference ID/Investigator# 116880 | Philadelphia | Pennsylvania | 19104 | — |
| Site Reference ID/Investigator# 116467 | Philadelphia | Pennsylvania | 19134 | — |
| Site Reference ID/Investigator# 116466 | Pittsburgh | Pennsylvania | 15224 | — |
| Site Reference ID/Investigator# 116462 | Charleston | South Carolina | 29425 | — |
| Site Reference ID/Investigator# 116453 | Sioux Falls | South Dakota | 57105 | — |
| Site Reference ID/Investigator# 116875 | Knoxville | Tennessee | 37916 | — |
| Site Reference ID/Investigator# 116856 | Houston | Texas | 77030 | — |
| Site Reference ID/Investigator# 116459 | Tyler | Texas | 75708 | — |
| Site Reference ID/Investigator# 116278 | Norfolk | Virginia | 23507 | — |
| Site Reference ID/Investigator# 116460 | Richmond | Virginia | 23219 | — |
| Site Reference ID/Investigator# 116438 | Morgantown | West Virginia | 26506 | — |
| Site Reference ID/Investigator# 116439 | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01858519, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 9, 2020 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01858519 live on ClinicalTrials.gov.